Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Trojaniello

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|June 28, 2021
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted ImmunotherapyClaudia Trojaniello, Jason J Luke, Paolo A Ascierto
Current Opinion in Oncology|January 5, 2021
Triplet combination of BRAF, MEK and PD-1/PD-L1 blockade in melanoma: the more the better?Claudia Trojaniello, Maria G Vitale, Paolo A Ascierto
Expert Review of Clinical Pharmacology|September 1, 2018
Selecting immuno-oncology-based drug combinations - what should we be considering?Lucia Festino, Vito Vanella, Claudia Trojaniello, et al.
Current Oncology Reports|March 30, 2023
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons LearnedClaudia Trojaniello, Francesca Sparano, Eleonora Cioli, et al.
Expert Review of Clinical Pharmacology|January 18, 2019
Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutationsClaudia Trojaniello, Lucia Festino, Vito Vanella, et al.
Recenti Progressi in Medicina|October 2, 2020
[Cutaneous squamous cell carcinoma: immunotherapy for locally advanced and metastatic disease]Luigi Scarpato, Ester Simeone, Claudia Trojaniello, et al.
Current Oncology Reports|June 28, 2026
Anti-PD-1 Combinations: Triplets and BeyondClaudia Trojaniello, Antonella Lucia Marretta, Bianca Arianna Facchini, et al.
Expert Review of Anticancer Therapy|March 21, 2020
Melanoma immunotherapy: strategies to overcome pharmacological resistanceClaudia Trojaniello, Maria Grazia Vitale, Luigi Scarpato, et al.
Current Oncology Reports|July 31, 2019
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy EraVito Vanella, Lucia Festino, Claudia Trojaniello, et al.
Molecular and Clinical Oncology|September 1, 2017
Severe blood loss anaemia and recurrent intussusceptions as first presentation of bowel metastatic renal cell carcinoma: A case report and review of the literatureClaudia Trojaniello, Maria Giuseppa Vitale, Biagio Trojaniello, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|June 28, 2021
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted ImmunotherapyClaudia Trojaniello, Jason J Luke, Paolo A Ascierto
Current Opinion in Oncology|January 5, 2021
Triplet combination of BRAF, MEK and PD-1/PD-L1 blockade in melanoma: the more the better?Claudia Trojaniello, Maria G Vitale, Paolo A Ascierto
Expert Review of Clinical Pharmacology|September 1, 2018
Selecting immuno-oncology-based drug combinations - what should we be considering?Lucia Festino, Vito Vanella, Claudia Trojaniello, et al.
Current Oncology Reports|March 30, 2023
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons LearnedClaudia Trojaniello, Francesca Sparano, Eleonora Cioli, et al.
Expert Review of Clinical Pharmacology|January 18, 2019
Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutationsClaudia Trojaniello, Lucia Festino, Vito Vanella, et al.
Recenti Progressi in Medicina|October 2, 2020
[Cutaneous squamous cell carcinoma: immunotherapy for locally advanced and metastatic disease]Luigi Scarpato, Ester Simeone, Claudia Trojaniello, et al.
Current Oncology Reports|June 28, 2026
Anti-PD-1 Combinations: Triplets and BeyondClaudia Trojaniello, Antonella Lucia Marretta, Bianca Arianna Facchini, et al.
Expert Review of Anticancer Therapy|March 21, 2020
Melanoma immunotherapy: strategies to overcome pharmacological resistanceClaudia Trojaniello, Maria Grazia Vitale, Luigi Scarpato, et al.
Current Oncology Reports|July 31, 2019
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy EraVito Vanella, Lucia Festino, Claudia Trojaniello, et al.
Molecular and Clinical Oncology|September 1, 2017
Severe blood loss anaemia and recurrent intussusceptions as first presentation of bowel metastatic renal cell carcinoma: A case report and review of the literatureClaudia Trojaniello, Maria Giuseppa Vitale, Biagio Trojaniello, et al.
Pageof 4